Health service overhaul of diabetes treatment calls for ramped-up use of Ozempic and Mounjaro
Health service overhaul of diabetes treatment calls for ramped-up use of Ozempic and Mounjaro
Copy link
Diabetes patients could be offered weight loss jabs sooner in major shake-up
Ozempic sales surge ‘up to 600%’ after Mounjaro price rises
Diabetes drug Ozempic will cost half-price for US patients paying cash
True cost of the UK’s obesity crisis revealed – and how weight-loss jabs could be key
Millions of people ‘could be denied weight-loss jabs due to flawed NHS guidance’
About 220,000 patients expected to receive Mounjaro over three years as GPs can prescribe the drugs for the first time
The changes will impact millions of people with type 2 diabetes in England in the biggest shake-up of care in a decade
Around 29% of the adult population in the UK is obese
Drug to initially be offered to people with BMI over 40 with at least four other health problems linked to obesity
GPs warned of surge in demand for Mounjaro from health service following hike by US pharmaceutical firm
Weight-loss drug Mounjaro will be rolled out to a quarter of a million NHS patients. But leading experts tell Rebecca Thomas and…
